Use of nucleoside reverse transcriptase inhibitors was associated with a reduced risk for developing dry age-related macular degeneration, according to a study published in Proceedings of the National Academy of Sciences.
“We are extremely excited that the reduced risk was reproduced in all the databases, each with millions of patients,” Jayakrishna Ambati, MD, founding director of the University of Virginia’s Center for Advanced Vision Science, co-founder of Inflammasome Therapeutics and one of the study’s authors, said in a press release issued by UVA Health. “This
Uncategorized